EFFECTIVENESS OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV-23) IN THE PREVENTION OF HOSPITALIZATIONS DUE TO VACCINE-TYPE PNEUMOCOCCAL PNEUMONIA (ID 811)

Session Name
Vaccines - Impact of Vaccine programs and Serotype Replacement
Presenter
  • Julio Ramirez, United States of America
Authors
  • Julio Ramirez, United States of America
  • Stephen Furmanek, United States of America
  • Senen Pena, United States of America
  • William Mattingly, United States of America
  • Forest Arnold, United States of America
  • Tim Wiemken, United States of America
  • Ruth Carrico, United States of America
  • The Louisville Pneumonia Study Group, United States of America